HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduced-intensity cord blood transplantation without prior remission induction therapy induces durable remission in adult patients with relapsed acute leukemia after the first allogeneic transplantation.

AuthorsToshimitsu Ueki, Masahiko Sumi, Keijiro Sato, Ikuo Shimizu, Daigo Akahane, Mayumi Ueno, Naoaki Ichikawa, Shinji Nakao, Hikaru Kobayashi
JournalEuropean journal of haematology (Eur J Haematol) Vol. 86 Issue 3 Pg. 268-71 (Mar 2011) ISSN: 1600-0609 [Electronic] England
PMID21114536 (Publication Type: Letter)
Chemical References
  • Tacrolimus
Topics
  • Adolescent
  • Adult
  • Cord Blood Stem Cell Transplantation (adverse effects, methods)
  • Female
  • Graft vs Host Disease (prevention & control)
  • Graft vs Leukemia Effect
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Leukemia, Myeloid, Acute (therapy)
  • Male
  • Middle Aged
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (therapy)
  • Recurrence
  • Remission Induction
  • Tacrolimus (administration & dosage)
  • Transplantation Conditioning (methods)
  • Transplantation, Homologous
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: